hers hims semaglutide Sell & Stock. The Weight-Loss Drug Surge Is Fading Fast A New Era of Weight

Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes

Serious adverse events and mortality Incidence of serious adverse events did not differ between any of the tirzepatide doses and any comparator (ESM Table 3)

Management of late onset urea cycle disordersa remaining challenge for the intensivist

Plasma insulin levels were not significantly different between d-allulose and saline groups at 0, 15, 30 min in ipGTT, however, in the presence of d-allulose insulin level significantly increased at 15 min compared to 0 min (Fig

p = 0.007), with a trend towards increased HF with alogliptin in EXAMINE (HR: 1.19

Sies H, Mailloux RJ, Jakob U